RoosterBio Inc.
Accelerating hMSC & Exosome Product & Process Development to Fuel Rapid Implementation of Scalable Advanced Therapies
Frederick, United States
52 employees
Series Unknown
Total: $40.15M
Biotechnology, Medical Devices
General Information
Get notified when RoosterBio Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track RoosterBio Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About RoosterBio Inc.
Taxonomy: Regenerative Medicine, Stem Cells, Cell Manufacturing, Advanced Therapies, Process Development, hMSCs, Exosome, Sustainable Industry, Media Systems, Collaborative Relationships, Standardization, Cost Savings, Innovation
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 08 Mar 2024 | |
| Debt Financing | •••••• | - | 08 Mar 2024 | |
| Series B | •••••• | 3 |
|
11 Sep 2019 |
| Series B | •••••• | 1 |
|
06 Aug 2019 |
| Grant | •••••• | 1 | •••• •••• | 13 Jun 2019 |
RoosterBio Inc. Alternatives & Competitors
A cell-therapy technology company developing artificial membrane-binding proteins for oncology and r...
The Global Leader in Exosome-based Therapeutics
Plasticell is a biotechnology company that develops novel therapies through precise manipulation of...
FAQ About RoosterBio Inc.
Don't just browse. Track.
Signal Tracker monitors RoosterBio Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.